[{"uuid": "7e689c3c-c420-37d8-b177-316535eb844f", "title": "HNO International Secures $10 Million Hydrogen Offtake Agreement with Texas-Based Mobility Company", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hno-international-secures-10-million-130000068.html", "providerPublishTime": 1738242000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pPvEPtJae3pasWgfq8ot2g--~B/aD0yNDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/472418cc6e52b9a5da8bb24b5bb38c6e", "width": 400, "height": 240, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z3BRk.BA5GHIch1IEt4uFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/472418cc6e52b9a5da8bb24b5bb38c6e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HNOI"]}, {"uuid": "1d1f472b-5eba-34d8-8fb8-886e89831158", "title": "RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/rdy-q3-earnings-match-estimates-160700099.html", "providerPublishTime": 1737734820, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/n5SbNKsJsCKv7joAIRd2zA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["RDY"]}, {"uuid": "6f59ce52-ed3e-3b14-9c17-e9ebe24c0546", "title": "Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/coherus-presents-final-phase-2-120000655.html", "providerPublishTime": 1737547200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/c44XrZdHt3bMpdwrfeLY5A--~B/aD0yNDQ7dz05ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 980, "height": 244, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/VaJZl1T8eKR3sWvYpw.hTQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CHRS"]}, {"uuid": "510b0085-c0fd-33cb-a19e-72872bd15f44", "title": "HNO International Targets NASDAQ Uplist and Capital Raise with Respected Investment Banking Firm", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hno-international-targets-nasdaq-uplist-130000592.html", "providerPublishTime": 1736859600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pPvEPtJae3pasWgfq8ot2g--~B/aD0yNDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/472418cc6e52b9a5da8bb24b5bb38c6e", "width": 400, "height": 240, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z3BRk.BA5GHIch1IEt4uFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/472418cc6e52b9a5da8bb24b5bb38c6e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HNOI"]}, {"uuid": "1bad19ee-e0c4-3ae3-a59a-db31f37fa2ce", "title": "Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/coherus-management-present-43rd-annual-130000836.html", "providerPublishTime": 1736341200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/c44XrZdHt3bMpdwrfeLY5A--~B/aD0yNDQ7dz05ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 980, "height": 244, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/VaJZl1T8eKR3sWvYpw.hTQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CHRS"]}, {"uuid": "bd7cd001-8658-3909-9c9e-c3d041ab8bd7", "title": "Coherus BioSciences (CHRS) Reports Q3 Loss, Tops Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/coherus-biosciences-chrs-reports-q3-221514376.html", "providerPublishTime": 1730931314, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83", "width": 900, "height": 633, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1wWgvR9AXA1o_EfTypadHw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CHRS"]}, {"uuid": "5c4fbb64-7c47-3e18-9b1b-7e758bf95364", "title": "Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/coherus-present-final-phase-2-133000716.html", "providerPublishTime": 1734528600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/c44XrZdHt3bMpdwrfeLY5A--~B/aD0yNDQ7dz05ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 980, "height": 244, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/VaJZl1T8eKR3sWvYpw.hTQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2735b7c71f366d11799f3c657ae3c6a4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CHRS"]}, {"uuid": "f4441aa3-4872-3fa8-ab0e-42948b44a28d", "title": "Coherus BioSciences to Divest Udenyca to Intas Pharmaceuticals for Up to $558 Million", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/coherus-biosciences-divest-udenyca-intas-124722958.html", "providerPublishTime": 1733230042, "type": "STORY", "relatedTickers": ["CHRS"]}, {"uuid": "cbef602f-0ee3-37cf-aced-3d311858f645", "title": "HNO International's Chairman & CEO Releases Exclusive 'Hydrogen Economy Vision' Video Interview from the NASDAQ Marketsite", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/hno-internationals-chairman-ceo-releases-130000356.html", "providerPublishTime": 1734699600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pPvEPtJae3pasWgfq8ot2g--~B/aD0yNDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/472418cc6e52b9a5da8bb24b5bb38c6e", "width": 400, "height": 240, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z3BRk.BA5GHIch1IEt4uFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/472418cc6e52b9a5da8bb24b5bb38c6e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HNOI"]}, {"uuid": "71f739a5-b104-3474-9b60-36e4026400c6", "title": "College Student With $400K In Stocks Grown In Just 4 Years Gets Mixed Reddit Advice \u2013 'Should I Max Out My Roth IRA And Invest In S&P 500?'", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/college-student-400k-stocks-grown-180014170.html", "providerPublishTime": 1734631214, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nJsIlYXvYQ.98.IpwmfUtA--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/3f5804edeb828775a2c52bb438f80919", "width": 720, "height": 480, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dORjxmtWf7EQ22slUR2b_A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/benzinga_79/3f5804edeb828775a2c52bb438f80919", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["^GSPC", "RDDT"]}, {"uuid": "07a173cd-db3c-3c73-b2f3-98ed7f4081a1", "title": "Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/coherus-biosciences-inc-chrs-q3-072632285.html", "providerPublishTime": 1730964392, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/LByHCOi5VWdNg3YN0ac1eg--~B/aD00MTk7dz00MTk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f629292a7780ed8ec1d409a71dcac9b3", "width": 419, "height": 419, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/HrM3vzGPBIiw3La32pc4Rw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/f629292a7780ed8ec1d409a71dcac9b3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CHRS"]}, {"uuid": "c1e6c03d-36fe-3b82-b6a9-87c968176d6b", "title": "RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/rdy-launches-loqtorzi-biosimilar-india-150900580.html", "providerPublishTime": 1732892940, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/4qYAeIby_0fxQYGokmloZw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/_cD2UyIEHIJ5d.vXrEcDjQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE"]}]